Portal de Periódicos da CAPES

Targeting Ferroptosis to Iron Out Cancer

2019; Cell Press; Volume: 35; Issue: 6 Linguagem: Inglês

10.1016/j.ccell.2019.04.002

1878-3686

Behrouz Hassannia, Peter Vandenabeele, Tom Vanden Berghe,

RNA modifications and cancer

One of the key challenges in cancer research is how to effectively kill cancer cells while leaving the healthy cells intact. Cancer cells often have defects in cell death executioner mechanisms, which is one of the main reasons for therapy resistance. To enable growth, cancer cells exhibit an increased iron demand compared with normal, non-cancer cells. This iron dependency can make cancer cells more vulnerable to iron-catalyzed necrosis, referred to as ferroptosis. The identification of FDA-approved drugs as ferroptosis inducers creates high expectations for the potential of ferroptosis to be a new promising way to kill therapy-resistant cancers.